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Despite the personal and cultural importance of childbearing in India, limited information 
exists on the extent of childbearing desires and intentions among HIV-infected 
individuals in this setting. The purpose of this study was to measure the extent of 
childbearing desires among HIV-infected individuals in Chennai, India, thereby testing 
the hypothesis that HIV significantly influences the desire to have children.  Three 
hundred HIV-infected individuals were interviewed about childbearing desires and 
intentions during routine visits for HIV care at an HIV specialty care clinic in Chennai, 
South India.  Sixteen percent of participants expressed desire for childbearing, and 9% 
expressed intention to have children in the future.  Desire for children was associated 
with childlessness (OR 7.38, 95% CI 3.18-17.15), longer time since diagnosis with HIV 
(OR 2.187, 95% CI 1.511-5.511), and absence of financial concerns about bearing 
children (OR 3.81, 95% CI 1.77-8.21).  Childbearing desires decreased with increasing 
age (OR 0.922, 95% CI 0.87-0.98).  Childbearing desires were not associated with 
measures of disease progression.  The most frequently cited concerns about childbearing 
among participants were the potential of infecting the infant (71%) followed by the 
burden of the participant’s own illness (49%).  Thirty-five percent of participants 
reported lack of knowledge about reducing transmission of HIV for couples trying to 
conceive.  Although 84% of the cohort expressed no desire for childbearing, nearly half 
(48%) of those without desire stated that in the absence of HIV infection they would 
desire and or intend to have children.  When compared with individuals who desired 
children regardless of HIV infection, these individuals were more inclined to have at least 
one child already, resided in the state of Andhra Pradesh, had known their diagnosis for a 
  
shorter time, and had more childbearing concerns related to HIV infection.  Although the 
prevalence of childbearing desire and intent are lower among this population than in 
HIV-infected populations studied in other settings, it is likely that childbearing among 
HIV-infected individuals in India will become increasingly important as HIV-infected 
patients live longer and healthier lives through increasing access Highly Active 
Antiretroviral Therapy (HAART) in India.  
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According to UNAIDS there are an estimated 2.5 million people, or 0.36% of the 
general population, living with HIV in India, with the majority of known cases in males.   
In the southeastern state of Tamil Nadu the prevalence is estimated to be as high as 
0.65% among women presenting to antenatal clinics.  More than 80% of reported AIDS 
cases are due to heterosexual transmission (1).   One retrospective study demonstrated 
that marriage, monogamy, and heterosexual intercourse were the only identifiable risk 
factors among HIV-infected women presenting to an HIV tertiary care center in south 
India, illustrating that for many, HIV-infection occurs within the context of marriage (2).   
Individuals infected with HIV in the context of marriage, as well as unmarried 
individuals considering marriage, face decisions about reproduction since bearing and 
raising children are integral to married life in India. 
Broadly speaking, the interplay of complex biological, psychological, and social 
factors—including personality, value systems, beliefs about pregnancy, birth and 
parenthood, influence of spouse, parents and community, major life events, social 
support, and barriers or facilitators—all inform the decision and motivation to bear 
children for any individual (3).   HIV infection adds layers of complexity to decision-
making around childbearing, and its influence on these desires and intentions differ 
depending on the personal, social, and biomedical context (4). For example, in one 
scenario family members or one’s partner might pressure an HIV-infected individual to 
have children because of cultural norms, or in an alternative scenario they might 
discourage childbearing because of disapproval associated with HIV infection (5).  
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In India, where the number of children per couple in 2005 was 2.9,the cultural and 
societal pressure to bear children is widespread and pervasive (6).  Little social science 
research has explored the direct consequences of being childless in India.  However, it is 
broadly known that a woman’s place and security in her husband’s family depends upon 
her ability to produce offspring.  Failure to conceive or successfully bear children is 
commonly blamed on the wife, and can lead to divorce, abandonment and abuse (7).   
Studies examining factors associated with domestic violence have demonstrated that 
childlessness is associated with significantly higher risk of recent domestic violence (8). 
In this cultural context, the expectation that women will bear children is so 
profoundly culturally embedded that the stigma and psychological burden associated with 
failure to do so may be greater for some than the burden associated with HIV.  Pregnancy 
requires unprotected sexual intercourse, which in the case of discordant couples—couples 
where one partner is infected with HIV and the other is not—means risking transmission 
from one partner to the other (9).  Pregnancy, childbirth and breast-feeding all involve 
risk of vertical transmission from mother to infant.  In addition to the risk of 
transmission, living with HIV places additional health, social and financial burdens on 
both parents and children.  Despite these risks, many HIV-infected individuals continue 
to have children, and those who do not may still be grappling with the decision and its 
consequences. 
Much emphasis in resource-limited settings has been placed on limiting 
unplanned pregnancies, particularly in the context of HIV, given the risks of vertical and 
horizontal transmission of the virus (4, 10).  In some settings, HIV-infected individuals 
report that they have not discussed reproduction with healthcare providers because of 
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perceived negative reactions (5).  However, if policy and counseling efforts focus solely 
on discouragement of reproduction while ignoring the complexity of peoples’ true desires 
and intentions or education, they may actually fuel sexual and mother to child 
transmission of HIV rather than addressing the factors that inform these decisions (9).  
Understanding how HIV-infected individuals reconcile their illness with the desire to 
bear children is essential in counseling appropriately about reducing risks of transmission 
and addressing individuals’ family planning needs and reproductive desires.   
Historically, before the advent of Highly Active Antiretroviral Therapy (HAART) 
when risk of mother to child transmission was high, pregnancy was strongly discouraged 
among HIV-infected individuals in high-income settings, such as the United States (11). 
In 1985, the CDC advised against pregnancy for HIV-infected women citing poor 
prognosis, possible complications and risk of vertical transmission (12, 13).  These 
recommendations were echoed by the American College of Obstetrics and Gynecology, 
which also advised against pregnancy for HIV-infected women in 1987 (14, 15).    
However, the advent of HAART, which dramatically increased quality of life and 
longevity and significantly reduced rates of mother to child transmission, in conjunction 
with assisted reproductive options, caused shifts in policy and recommendations in high-
income settings (12).  In 1994 the 076 trial of the Pediatric AIDS Clinical Trial Group 
(PACTG) demonstrated that treatment with zidovudine (AZT) reduced the rate of mother 
to child transmission to 8% among those treated compared with a 25% transmission rate 
in the untreated group (16).  Administration of AZT and scheduled cesarean section 
before rupture of membranes, in conjunction with avoidance of breastfeeding, was found 
to further reduce mother to child transmission to 2% (17, 18).  Suppression of HIV RNA 
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viral load to less than 1000 copies/mL through administration of HAART can also reduce 
vertical transmission to 1% to 2% regardless of mode of delivery (18).  Consequently in 
2001, the CDC changed its recommendations, no longer advising against pregnancy 
among HIV-infected women, but rather stating that HIV-infected pregnant women should 
receive counseling and information about reproductive options.  Current guidelines by the 
Public Health Service Task Force at the CDC provide detailed recommendations for 
preconceptual and prenatal counseling, about use of antiretrovirals during pregnancy and 
use of elective cesarian section so that women can make informed decisions (19).  ACOG 
also revised recommendations indicating that HIV-infected individuals should have the 
same access to assisted reproductive technologies as their uninfected counterparts. (12)   
Research from high-income settings exploring childbearing desires, intentions, 
and decision-making has demonstrated that HIV-infected individuals desire children (20, 
21, 22, 23, 15, 24).  Even before HAART for prevention of mother to child transmission 
(PMTCT), HIV-infected individuals continued to desire and bear children despite the 
high risk of transmission and recommendations against pregnancy and childbearing (25).  
A later study examining fertility desires and intentions among a nationally representative 
sample of HIV-infected men and women receiving treatment in the U.S. demonstrated 
that 28-29% of them desired children, which was lower than the proportion of women in 
the US who desire children.  Of those desiring children, 31-41% expected or intended to 
have them in the future.  In this study, younger individuals with fewer children who 
reported higher overall health status were more likely to desire children as were women 
whose partner’s HIV status was unknown.   However, childbearing desires were not 
related to disease progression. (20)  
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Access to HAART allows individuals infected with HIV to live longer with 
improved quality of life and decreases risk of mother to child transmission of HIV, which 
influences reproductive decision-making in resource plentiful settings.  A U.S. study 
suggested that implementation of the Pediatric AIDS Clinical Trial Group Protocol 076 
resulted in fewer HIV-infected women choosing postpartum sterilization and maintaining 
options for future fertility (26). These results imply that in addition to increased longevity 
for those living with HIV, the reduced risks of vertical transmission may influence 
reproductive decision-making.  A more recent study finding that the HAART-era birth 
rate among HIV-infected women was 150% higher than the pre-HAART era birthrate as 
opposed to 5% higher in uninfected counterparts, provides further compelling evidence 
that HAART has had a profound impact on child-bearing in this setting (24).  This study, 
however, did not specify whether the increased birth rate was due to increased decisions 
to bear children or a result of improved health and consequent increased fertility. 
In addition to administration of HAART for PMTCT, other assisted reproductive 
technologies exist, which are limited to high-income settings because of high costs (15).  
Among sero-discordant couples, in addition to the risk mother to child transmission, there 
is risk of horizontal transmission—from the HIV-infected partner to the uninfected 
partner.  Even among sero-concordant couples, meaning couples where both partners are 
HIV-infected, unprotected sexual contact introduces the risk of transmission of drug-
resistant strains of the virus from one partner to the other (27).  Studies have shown that 
consistent use of condoms among sero-discordant couples, where the male partner is 
infected and the female partner uninfected is 69%-94% effective at preventing 
transmission (28, 29).  Obviously, however, for couples that wish to conceive, condoms 
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also prevent the desired pregnancy.  In such couples, assisted reproductive technologies, 
which reduce risk of transmission without preventing pregnancy, are available.  Sperm 
washing isolates spermatazoal cells from nonspermatazoal and seminal cells, which are 
the reservoirs for HIV (30, 31).  A retrospective multi-center study examining the safety 
and efficacy of sperm washing in 1036 HIV-1 sero-discordant couples in Europe 
demonstrated that sperm washing significantly reduced the risk of transmission to the 
female partner (32).  Another perhaps less expensive, but riskier option for sero-
discordant couples wishing to conceive involves suppressing the male partner’s viral load 
through antiretroviral treatment and then limiting unprotected sexual contact to the most 
fertile period of the female partner’s menstrual cycle.  HIV sero-concordant couples can 
also use this method of timed intercourse to reduce risk of transmission of drug resistant 
virus. (28)  However, the technique requires education and financial and technological 
resources to monitor viral load and ovulation.  In sero-discordant couples where the 
female partner is infected, the obvious choice is artificial insemination, where women can 
inseminate themselves at very low costs, as opposed to in vitro fertilization, which is a 
more costly option (33).  The success of minimizing risk of transmission under these 
circumstances would then be contingent upon access to PMTCT.  These techniques, 
while innovative and viable options in resource-plentiful settings are expensive and 
largely unavailable in resource-limited settings, where basic access to PMTCT is still 
limited. 
As access to HAART improves in resource-limited settings, it is possible that it 
will influence reproductive decision-making in these settings, given its profound impact 
on childbearing among HIV infected individuals in high-income settings (24).  Access to 
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HAART in India has increased significantly over the past seven years.  According to 
UNAIDS/WHO, 785,000 of the 5.7 million people living with HIV in India need 
antiretroviral therapy.  Generic antiretroviral therapy became available in India in the 
year 2000, which meant that first-line therapy was then available for US $1 per day.  Cost 
of first-line combination therapy of stavudine, lamivudine and nevirapine has further 
declined to US $146 per person per year (34). The government of India has committed to 
providing ART free of cost at government ART Centers (127 of them as of June 2007) as 
part of its National AIDS Control Program (35).  By December 2005, 60,000 people 
requiring ART were receiving it, 24,000 receiving it free through the government 
program, another 10,000 receiving it free through intersectoral partners, and 10,000-
20,000 were receiving it from other sources (34).    
A study investigating the impact of the introduction of generic HAART at the 
large HIV clinic where this study was conducted found a dramatic increase in the number 
of people seeking treatment for HIV between 1996 and 2003 and a 20% increase in the 
number of people who could afford therapy after the introduction of generics in the year 
2000, most probably because patients are more likely to seek care if they believe that they 
will have access to affordable therapy (36).  After the year 2000 and availability of 
generic HAART, Kumarasamy et al also observed a dramatic change in the natural 
history of the disease at this center.  The number of individuals seeking treatment for 
infections decreased by 20-fold, and the death rate decreased from 25 to 5 per 100 person 
years between 1997 and 2003 (36).   
In resource-limited settings, risk of mother to child transmission is estimated to be 
15%-25% among non-breastfeeding infants of HIV-infected mothers and 25%-45% 
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among breastfeeding infants (11).  PMTCT programs are available in resource-limited 
settings including India.  A review of national programs in 71 countries for 2004-2005 
indicated that PMTCT increased from 7% in 2004 to 11% in 2005, with 8% of infants 
born to HIV-infected mothers receiving antiretroviral prophylaxis (37).  However, in 
2006 less than 10% of estimated HIV-infected women actually received antiretrovirals 
for PMTCT worldwide (38).   
The World Health Organization (WHO) 2006 guidelines for PMTCT in resource-
limited settings outline an approach, which maximizes benefits and minimizes costs 
through simplified, standardized regimens.  These guidelines can be adapted based on the 
context of the patient and resources available (38, 39).  The guidelines describe a tiered 
approach, which includes a triple drug regimen for women who require HAART for their 
own health.  Women who do not yet need HAART for their own health should take a 
short course regimen, which includes nevirapine.  Infants should receive nevirapine and 
zidovudine.  Although less effective, a nevirapine single dose regimen is recommended 
where other regimens are not currently feasible.  Appropriate intervention among 
breastfeeding populations is unclear and still under investigation.  (38, 39) 
As access to HAART improves in India and other resource-limited settings, 
allowing HIV-infected individuals live longer, healthier lives and reducing rates of 
mother to child transmission, it is important to assess the extent of fertility desires and 
intentions and the implications for vertical and heterosexual transmission in these 
settings.  Several studies in resource-limited settings have explored reproductive desires, 
intentions, and decision-making among HIV-infected individuals and shown that HIV-
infected individuals continue to desire and bear children in these contexts (40, 41, 42, 43, 
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44). One study addressing reproductive decision-making among HIV-infected individuals 
in Nigeria, found that the reproductive intentions and desires in the region were high.  
Sixty-three percent of HIV-infected individuals surveyed desired children, and of those 
desiring children, 71.5%-93.8% intended to have children in the future (44).  Another 
study in Uganda found that 18% of individuals infected with HIV who were surveyed 
desired more children, with many more than that, 33%, practicing unprotected sex and 
thus risking pregnancy.  In this study men were four times more likely to desire children 
than women.  PMTCT knowledge was high and did not correlate with desire for children, 
however knowledge did correlate with less unprotected sex and thus less risk of 
pregnancy (42).  A Brazilian study surveying HIV-infected women found that 45% 
desired children in the future (41).  A qualitative study in Capetown, South Africa 
exploring reproductive decision-making among HIV-infected individuals suggested that 
fear of transmission, financial concerns, family pressure, disclosure, and community 
attitudes influence individuals’ childbearing decisions (40).  To our knowledge no such 
study examining the reproductive desires and intentions among HIV-infected individuals 
has previously been conducted in India, where the HIV epidemic and the cultural context 
affect women uniquely. 
The primary aim of this study was to assess the extent of reproductive desires and 
intentions in HIV-infected individuals in an HIV care center in South India, and to 
examine socio-demographic and health-related factors associated with the desire and 
intention to bear children in this population.   A secondary aim was to assess HIV-
infected individuals’ knowledge about reproductive options that would reduce the risks of 




This study was conducted at Y.R. Gaitonde Center for AIDS Research and 
Education (YRG CARE), a non-governmental HIV specialty care center located in 
Chennai, in the state of Tamil Nadu, South India.  Since its inception in 1996, more than 
10,000 patients infected with HIV have been in care at the center, with approximately 
2000-3000 patients currently receiving ongoing care.  YRG CARE provides 
comprehensive services, including voluntary counseling and testing services, 
psychosocial counseling, inpatient and outpatient treatment facilities, laboratory 
monitoring, as well as nutritional support for people living with and affected by HIV. 
 
Data Collection   
A semi-structured questionnaire, consisting of 18-23 questions pertaining to the 
participant’s reproductive history, contraceptive practices, reproductive desires and 
intentions, and knowledge about reproductive options for reduction of horizontal and 
vertical transmission, was administered in a face-to-face interview in the language best 
understood by the participant, either Tamil or Telegu.  The questionnaires were translated 
from English to Tamil and Telegu and then back-translated to English for verification 
prior to the commencement of data collection.  The answers to open-ended questions 
about the reasons for desiring children and concerns about bearing children were coded 
by the interviewer according to categories established from a review of relevant literature 
about childbearing decision-making among HIV-infected individuals in other settings.  
General demographic, medical and socio-economic information was obtained from the 
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patient’s clinic record.  The most recent CD4 count and the lowest CD4 count were 
obtained from a review of each patient’s medical record.  A history of opportunistic 
infections and prior hospitalizations was obtained from the YRG CARE HIV 
Observational Database (45). 
This study was approved by the institutional review board at YRG CARE and by 
the Yale Human Investigations Committee. 
 
Study Sample 
The questionnaire was administered to previously diagnosed HIV-infected men 
and women presenting for routine care between February and April 2007.  Patients were 
eligible to participate if they were female between the ages of 18-40 or male between the 
ages of 21-50.  Females reach age of majority in India at age 18, whereas age of majority 
for males is 21.  Patients were eligible if they had been in treatment at YRG CARE for a 
minimum of five months, so that they would have had time to develop relationships with 
their care providers.  Patients were eligible if they were either HAART naïve or had 
undergone no changes in their HAART regimen in the previous 3 months and had not 
experienced a WHO stage IV AIDS-defining diagnosis within the previous 3 months.  
These eligibility criteria were established to avoid obtaining responses that would be 
unduly influenced by an acute disease-related event. 
Three hundred eligible participants were recruited to participate in the study by 
counselors at YRG CARE.  The study was explained to participants and informed 




All statistical analysis was performed using SPSS software (version 10.0.5, 
Chicago, USA). Mean plus or minus standard deviation was used for variables which 
were normally distributed, and median, interquartile range (IQR), and range, if required, 
were used for variables that were influenced by extreme values.  
Chi-square test and t-test were conducted on categorical and continuous variables.  
Multivariate logistic regression was performed to study the relationship between the 
various socio-demographic characteristics, health-related characteristics, concerns about 
childbearing, and knowledge regarding methods to reduce transmission of HIV among 
respondents who desired children compared to those who did not desire to have children.  
A p-value of less than 0.05 was considered statistically significant.  
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RESULTS 
Among the 300 study participants, over one quarter were female (n=85, 28%).  
The mean age of participants was 35(6) years.  Most of the participants were married 
(n=259, 86%), while 8% (n=23) had been previously married, and 6% (n=18) had never 
been married.  Over half of the participants came from the state of Tamil Nadu (n=156, 
52%), followed by the state of Andhra Pradesh (n=131, 44%), just to the north of 
Chennai.  The remaining participants came from the neighboring southern states of 
Pondicherry, Kerala and Maharashtra (n=13, 4%).  Close to one-third of participants 
(n=106, 35%) were sero-discordant with their primary partner, meaning that their partner 
was not infected with HIV, and over half (n=168, 56%) were in sero-concordant 
partnerships, meaning that their partner was known by them to be HIV-infected, while 
few (n=10, 3%) had not had a partner since finding out their status or did not know the 
status of their partner (n=11, 5%).  Among the 265 patients who had a primary partner, 
almost all (n=265, 93%) had disclosed their HIV status to their partner.  Well over half of 
the respondents (n=164, 55%) had two or more children, just under one-third had one 
child (n=89, 30%), and less than one-sixth (n=46, 15%) of the respondents were 
childless.  The mean number of children among the participants was 1.3.  Among the 
women surveyed who had previously been pregnant, the mean age of first pregnancy was 
21.  Table I summarizes the general socio-demographic and health-related characteristics 
of the participants.  
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Table I. Characteristics of participants 
Sociodemographic characteristics 





Mean Age (SD), years  35(6) 
























































Mean (SD) age of first 
pregnancy among women, 
years 
 21(3) 




























Total participants  300 
Mean  (SD) time since 
diagnosis, months 
 48 (30) 
Time since diagnosis 5 months-1 year 
1 year-2 years 
2 years-3 years 
3 years-4 years 








Median (IQR) most recent 
CD4 count, cells/mL 
 370(241-538) 












Median (IQR) lowest CD4 
count, cells/mL 
 161(91-281) 






















History of AIDS-defining 









Mean (SD) duration on 
HAART, months 
 26(21) 
Duration on HAART 4 months-1 year 
1 year-2 years 






Mean (SD) time in care at 
YRG CARE 
 40(27) 
Time in care at YRG CARE 5 months-1 year 
1 year-2 years 
2 years-3 years 





































In terms of health status, on average the patients had been aware of their diagnosis 
for 4 years (mean: 48±30 months).  The median (IQR) most recent CD4 count was 
370(241-538), and the median (IQR) lowest CD4 count recorded 161(91-281).  One-third 
(n=99, 33%) of the participants had previously been diagnosed with an AIDS-defining 
opportunistic infection (OI), and just under one-third (n=86, 29%) had been hospitalized 
at least once during the history of their infection.  Over two-thirds (70%) of the 
participants were taking highly active antiretroviral treatment (HAART) at the time of the 
interview, and the mean duration on HAART was 26 (SD:21) months.  Ninety-five 
percent of the participants believed that HAART was effective at slowing the course of 
HIV infection regardless of whether or not they were taking HAART.  The participants 
had been receiving care at YRG CARE for a mean duration of 40 (SD:27) months. 
Among the 300 HIV-infected individuals interviewed, 16%(n=47) expressed 
desire to have at least one more child, whereas 9% (n=28), or 60% of those who desired a 
child, expressed the intention to actually bear more children.  So few participants 
expressed intention for childbearing that we were unable to compare them to those who 
did not intend to have children.   
Eighty-one percent of people surveyed were greater than 30 years of age, which 
suggests that older individuals may have been over-represented in this cohort.  However a 
separate analysis was done among individuals less than age 35, which showed that the 
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prevalence of childbearing desires among the younger group was similar, 19% as 
opposed to 16% in the entire cohort, and the associated factors among the younger 
participants were similar as well. 
Table II shows the percentage distribution of the study participants and the mean 
values by selected characteristics according to the desire for children.  Of those who 
desired children 74% were male and 26% were female which is similar to the sex 
distribution among those who did not desire children.  Men and women who desired 
children were younger than those who did not desire children (mean (SD) age 32(6) and 
35(6) respectively, p=0.005) and were more likely to have never married than those who 
did not desire to have a child (17% vs 4%; p<0.001).  The participants desiring children 
were more likely to be childless, and childbearing desires decreased with increasing 
number of children. The participants who desired children were more likely to have been 
pregnant or had a partner who had been pregnant since finding out that they were HIV-
infected than those who did not desire children.  The participants who desired children 
had been aware of their HIV diagnosis for longer time than those who did not desire 
children (41 months vs. 46 months; p=0.002).  However the desire for children was not 
significantly related to the level of disease severity in terms of the lowest CD4 count, a 
history of opportunistic infection or hospitalizations.  Desire for children was not 
significantly associated with whether or not the participants were taking HAART or with 
the duration on HAART among those who were taking it.   
The most frequently cited reason for desiring children was personal fulfillment 
(32%), followed by family pressure to bear children (28%), community pressure (13%), 
and a partner’s desire for a child (13%).  Fewer respondents cited desire for a child of a 
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specific sex as a reason for desiring another child.  Few people recognized the impact of 
treatment as a reason for desiring children, whether it was the impact of treatment on 
their own health or treatment as a means of reducing vertical transmission.  The reasons 
for desiring children among participants who desired them are summarized in Table IV. 
The most commonly expressed concern about childbearing was possible 
transmission of HIV to the offspring, which was cited by 213 (71%) of the respondents, 
regardless of whether or not they wanted to have children.  That predominating concern 
was followed by the burden of the respondent’s own illness.  Seventy-three of the 132 
participants who did not have a partner infected with HIV stated they would be concerned 
about transmitting HIV to a partner in the attempt to conceive.  Financial concern 
associated with bearing another child was expressed significantly more often among 
individuals who did not desire children (n=120, 47%) compared with those who desired 
children (n=9, 19 %, p<0.001).  Fifteen percent (n=7) of individuals desiring children 
versus 0% (n=1) of individuals not desiring children stated that they had no concerns 
about childbearing (p<0.001). 
Knowledge about reproductive options for reducing risks of transmission was not 
significantly associated with the desire for children.  However, among the entire cohort, 
35% reported no knowledge about methods of reducing vertical and horizontal 
transmission while trying to conceive, illustrated in Figure 1.  Fifty-four percent cited 
HAART for PMTCT as a means of reducing vertical transmission, with only 31% 
reporting knowledge about c-section as part of PMTCT, and 29% recognizing that 
formula-feeding played a part in PMTCT.   
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Table II. Percentage distribution of study participants and mean values by socio-
demographic characteristics according to desire for children  
Characteristic Desire children Do not desire children p 




































































































































Table III. Percentage distribution of study participants by HIV-related characteristics 
according to desire for children 
Characteristic Desire children Do not desire children p 
N(%) 47(16%) 253(84%)  


































Pregnancy since HIV status 












*only asked of participants with a partner 
 
Table III. Percentage distribution of study participants and mean values by health-related 
characteristics according to desire for children 
Characteristic Desire children Do not desire children p 
N(%) 47(16%) 253(84%)  
Mean (SD) duration since 
diagnosis, months 
41(30) 46(29) 0.002 
Duration since diagnosis of 
HIV 
5 months-1 year 
1 year-2 years 
2 years-3 years 
3 years-4 years 



















Mean (SD) duration of 
attendance at YRG, months 
49(28) 39(27) 0.011 
Duration of attendance at 
YRG 
5 months-1 year 
1 year-2 years 
2 years-3 years 





















396(261-593) 370(240-535) 0.347 
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Median (IQR) lowest CD4, 
cells/mL 
181(96-320) 160(82-271) 0.317 

















































Mean (SD) duration on 
HAART, months 
34(23) 28(21) 0.122 
Duration on HAART among 
patients receiving HAART 
4 months-1 year 
1 year-2 years 












































Table IV.  Reasons for desiring children 
Number of participants desiring children 47(100%) 




Partner desires a child 
Desire to have a male child 
Desire to have a female child 
Treatment working, patient feels healthy 














Table V. Percentage distribution of study participants and mean values by concerns and 
knowledge regarding reproductive options according to desire for children 
Characteristic Desire children Do not desire children p 
N(%) 47(16%) 253(84%)  
Concerns about bearing 
children 
Infecting infant 




Stigma associated with illness 































Knowledge about reproductive 
options 
None1 









































Desire for childbearing in 
absence of HIV 
Yes 
No 
Do not know 
   
 







1Subjects did not report known means of reducing transmission for HIV-infected couples wishing to 
conceive 
 23
Figure 1.  Knowledge about reproductive options that reduce vertical and horizontal 
transmission in HIV-infected couples wishing to conceive 
 
The results of univariate analysis, comparing those who expressed desire for 
children to those who did not desire children, summarized in Table VI, demonstrate that 
desire for childbearing was associated with younger age (odds ratio, 0.922; 95% CI=0.87-
0.98), being childless (odds ratio, 7.38; 95% CI=3.18-17.15), and being unmarried (odds 
ratio, 5.193; 95% CI=1.89-14.30).  Increasing number of children was associated with 
decreased childbearing desires (odds ratio, 0.051; 95% CI=0.012-0.221).  Absence of 
financial concern about having another child was also associated with desire for children 
(odds ratio, 3.81; 95% CI=1.77-8.21).  Greater than four years since the diagnosis of HIV 
was associated with the desire for children (odds ratio, 2.187; 95% CI=1.511-5.511).  In 










































childless (odds ratio, 8.992; 95% CI= 4.368-19.742) and with greater time since diagnosis 
(odds ratio, 3.024; 95% CI= 1.419-6.445). 
 
Table VI. Univariate and multivariate analysis of characteristics associated with desire 
for childbearing in entire cohort 
Characteristic Desire 
children 






 N=47 N=253 OR 95% CI  OR 95% CI 



















































































































*among participants with children 
Although 84% of the cohort expressed no desire for childbearing, nearly half 
(48%) of those without desire stated that in the absence of HIV infection they would 
desire and or intend to have children.  In order to assess the effect of HIV infection on the 
desire for children, we compared the group who openly expressed desire for children 
despite HIV infection, to those who stated that they did not currently desire children but 
would desire them in the absence of HIV.  These results are summarized in Tables VII-
XVI.  When compared with the 47 who expressed desire for children, the 121 who stated 
that they would desire children in the absence of HIV were not significantly older (mean 
age 32 vs. 35) and did not differ significantly according to gender.  Study participants 
who would have desired children in the absence of HIV infection are more likely to have 
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at least one child already (87% vs 47%, p<0.0001), tended to have a shorter duration 
since diagnosis and were more likely to live in the neighboring state of Andhra Pradesh 
(56% vs 28%, p=0.002) compared to participants who expressed desire for children 
regardless of HIV status (Table VII, Table IX).  However, desire for more children in the 
absence of HIV was not significantly associated with any measures of disease 
progression such as most recent or lowest CD4 count, history of opportunistic infections 
or history of hospitalizations (Table IX).  Individuals who expressed that they would 
desire children if they were HIV-negative were significantly more likely to express 
concern about vertical transmission, concern about the burden of their own illness and 
financial burden when compared with the participants who expressed desire for children 
regardless of HIV status (Table X).  Their knowledge about methods for reducing 
transmission among couples wishing to conceive was not significantly different than the 
participants who desired children regardless of their HIV status (Table X). 
The results of univariate and multivariate analysis, comparing those who would 
have desired children if they were HIV-negative to those who desired children regardless 
of their HIV status are summarized in Table XVI.  These results demonstrate that state of 
residence, already having a child, time since diagnosis, and concern about transmission of 
HIV infection to the infant were all related to the influence of HIV on reproductive 
desire.  Multivariate analysis demonstrates that participants who already had at least one 
child (odds ratio, 5.617; 95% CI=2.174-14.515) and resided in the state Andhra Pradesh 
(odds ratio, 3.560; 95% CI=0.012-0.221) were more likely to have had HIV status 
significantly influence their desire for another child.   
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Table VII.  Percentage distribution of study participants and mean values by socio-
demographic characteristics according to desire for children regardless of HIV status and 
desire for children in the absence of HIV infection 
Characteristic Desire Children Would desire children 
if HIV negative 
p 











Mean Age (SD) 32(5) 35(6) 0.029 
Age 
18 to 25 
26 to 35 




































































Number of children 
0 
1 






























Table VIII.  Percentage distribution of study participants and mean values by HIV-related 
characteristics according to desire for children regardless of HIV status and desire for 
children in the absence of HIV infection 
Characteristic Desire Children Would desire children 
if HIV negative 
p 
N(%) 47 121  












































Table IX.  Percentage distribution of study participants and mean values by health-related 
characteristics according to desire for children regardless of HIV status and desire for 
children in the absence of HIV infection 
Characteristic Desire Children Would desire children 
if HIV negative 
p 
N(%) 47 121  
Mean (SD) duration since 
diagnosis, months 
57(19) 48(21) 0.011 










Median (IQR) most recent CD4, 
cells/mL 
396(261-593) 332(207-506) 0.145 

















































Mean (SD) time on HAART, 
months 
34(23) 29(22) 0.239 














Table X. Percentage distribution of study participants and mean values by concerns and 
knowledge according to desire for children regardless of HIV status and desire for 
children in the absence of HIV infection 
Characteristic Desire Children Would desire children 
if HIV negative 
p 
N(%) 47 121  
Concerns about bearing 
children 
Infecting the partner 
Infecting infant 




































ART for discordants 
Sperm donation 
Sperm washing 














































Table XI. Univariate and multivariate analysis of characteristics associated with desire 
for childbearing in the absence of HIV infection 
Characteristic Desire 
children 







 N=47 N=121 OR 95% CI  OR 95% CI 














































































































































































Sixteen percent of HIV-infected individuals expressed desire for children in this 
sample of mostly married, male subjects, who for the most part already had at least one 
child, were diagnosed a mean of 4 years prior to the survey, and who had 
overwhelmingly disclosed their HIV status to their primary partner.  Despite pervasive 
cultural pressure to bear children, desire for children in this setting was less extensive 
than had been reported among HIV-infected individual in high-income countries (25-
45%) and in other resource-limited settings in Africa (18%-63%) (20, 23, 41, 42, 44).  
Those who desired children in this context tended to be younger, unmarried, and had no 
children or fewer children than those who did not desire more children.  Neither 
biological markers of disease progression nor exposure to HAART significantly impacted 
the desire for children.  However, HIV infection did play a significant role in the desire 
and the decision to bear children; nearly half of participants who did not express desire 
for children said that in the absence of HIV infection they would want more children.   
In this sample younger age is positively associated with desire for children, which 
is consistent with similar studies in a wide range of settings (20, 23, 41, 42, 44).  Being 
childless was the strongest predictor of childbearing desire in this cohort, which was also 
consistent with findings in resource-limited settings in Nigeria and Uganda (21, 44).  This 
may also explain why being unmarried was associated with desire for children, since 
individuals who were unmarried did not yet have any children.  Individuals without 
children were almost six times more likely to desire children than individuals with one or 
more children.  Likewise, individuals with one child were more inclined to desire another 
child compared with individuals who already had two or more.  These findings support 
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the possibility that concerns and stigma associated with being childless in this personal 
and socio-cultural context may outweigh people’s concerns about transmission, finances, 
and the burden of their illness.  
A similar study conducted in Nigeria, where desire for children was far more 
prevalent, noted that desire for childbearing was associated with nondisclosure (44).   In 
our cohort, the overwhelming majority of patients had disclosed at least to his or her 
primary partner, which may have been protective.  In addition to indicating a certain level 
of personal acceptance of HIV infection, disclosure may discourage people from bearing 
children because of stigma; once an individual’s HIV-status is disclosed, his or her family 
or community may be concerned about transmission to the child and discourage the 
individual from having children.  However, since respondents in our cohort had 
overwhelmingly disclosed their HIV status to their primary partner, we are unable to 
comment on any association between non-disclosure and desire or intention for 
childbearing in this setting.   
Childbearing desires appeared to be independent of health-related factors, such as 
most recent CD4 count, lowest CD4 count, or history of opportunistic infections, which is 
consistent with the Nigerian and Ugandan studies.  However, the finding that individuals 
with longer time since diagnosis have greater desire for children may suggest that those 
desiring children are more inclined to view HIV as a chronic disease rather than an 
imminently life-threatening illness. Although childbearing desires were not influenced by 
treatment with HAART, the significant association between the desire to bear children 
and longer duration since diagnosis, suggests that childbearing desires, and perhaps 
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intentions, may become increasingly prevalent as longevity improves through better 
access to treatment and specialized care.   
Other studies have suggested that improved availability of HAART, which allows 
people to live longer, healthier lives and reduces risks of mother to child transmission, 
has increased childbearing desires and intentions in settings like the U.S. and South 
Africa (24, 26, 40).  In our cohort, childbearing desires were not significantly associated 
with whether or not a patient was taking HAART or by the duration of treatment with 
HAART, which may appear to contradict findings that access to HAART increases 
childbearing among HIV-infected couples.  Our finding might be explained by several 
factors.  Nearly all patients interviewed believed in the effectiveness of HAART at 
slowing the progression of HIV regardless of their childbearing desires or intentions.  
Furthermore all participants who needed HAART had access to it (although this was not 
true of all patients with HIV in India), which means that there was no comparison group 
of individuals who did not have access to HAART in this study.  Since all participants 
believed in the effectiveness of HAART we are unable to comment on any association 
between participants’ belief in the effectiveness of treatment and their desire for 
additional children.   
Despite access to treatment among this study population and their nearly universal 
belief in the effectiveness of HAART at slowing infection, 46% of respondents did not 
identify HAART as a means for preventing mother to child transmission.  This finding 
suggests that although patients understood the role of HAART in slowing the progression 
of their own disease, the majority of them did not fully understand the role of HAART in 
preventing vertical transmission.  This finding might explain why the percentage that 
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expressed desire was relatively low (16%), similar to a study conducted in Uganda where 
the population surveyed did not have access to HAART and only 18% expressed desire 
for children (42).  This seeming lack of knowledge, particularly among the individuals 
desiring children, is surprising in this context of specialized care and ongoing counseling 
and argues for increased widespread efforts in education and dissemination of 
information about prevention of vertical transmission of HIV. 
Childbearing decisions in India, as elsewhere, are influenced by culture, religion, 
family structure, and perception of identity (46).  This study did not thoroughly 
qualitatively explore individuals’ complex reasons for desiring children, nor their 
concerns about bearing them.  Eighty-four percent of the cohort expressed no desire for 
childbearing.  However, nearly half of those without desire stated that in the absence of 
HIV infection they would desire and or intend to have children which suggests that being 
infected with HIV has a powerful influence on the decision of whether or not to bear 
children.  A comparison of the participants who would desire children in the absence of 
HIV to the group who desired children despite their HIV infection begins to illustrate the 
impact of HIV on the decision-making.  The participants who would have desired more 
children in the absence or HIV generally already had at least one child, and thus were 
potentially less susceptible to the cultural stigma or personal sense of loss from being 
childless.  They also tended to live in Andhra Pradesh, which suggests that individuals 
living in Tamil Nadu, in closer proximity to specialized HIV care, may be more willing 
to consider childbearing in the face of HIV infection.  The participants who would have 
desired more children in the absence of HIV also more commonly expressed concern 
about infecting the infant, concern over the financial burden (which may include the 
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current costs of HAART or the anticipated costs of eventual treatment), and the burden of 
illness as reasons for not bearing children than the participants who wanted children 
regardless of their HIV status.  This finding suggests that for the majority of individuals 
who would want children, concerns about the risks of childbearing in the context of HIV 
outweigh their desire or the personal and cultural importance of bearing more children. 
Since this study was conducted in a non-governmental specialized HIV care 
setting, and the study subjects were mostly male, married, had at least one child and had 
disclosed their HIV status to their primary partner, these findings may not be 
generalizable to the entire population of HIV-infected individuals in India.  The 
limitations of this study also include the potential of inter-interviewer inconsistency, as 
well as the format of face-to-face administration of the questionnaire as opposed to 
anonymous administration.  The reason for face-to-face interviews was the importance of 
including all participants regardless of whether or not they were literate, as well as the 
ability of counselors to address questions or concerns that arose after administration of 
the questionnaire.  However, participants may have been hesitant to disclose their true 
desires and intentions in this setting.  Another limitation was that this study did not 
address the influence of quality of life on the decision of whether or not to bear children, 
which has been shown to influence reproductive decision-making in other studies.  This 
meant that although we were able to use markers such as CD4 count and history of 
opportunistic infection as indicators of disease progression, we were not able to account 
for a patient’s more subjective understanding or experience of these factors and its 
relationship to their childbearing desires. 
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Future directions of research should include attitudes of health care professionals 
and policy makers about reproductive decisions among HIV-infected individuals.  An 
exploration of pregnancy risk behavior in this population in light of the stated desires and 
intentions would also be illuminating as would a comparison to the childbearing desires, 
intentions and decision-making among an HIV-infected cohort compared to uninfected 
controls. 
 In conclusion, this study, which is the first to explore the childbearing desires 
among HIV-infected individuals in India, illustrates that as people live longer with HIV, 
they are inclined to consider childbearing.  Although HIV influences people’s decisions 
about childbearing, in terms of the potential for infecting the infant, the burden of illness 
and financial burdens, it is likely that as access to HAART continues to improve, 
individuals with HIV will live longer lives, and childbearing will become a more pressing 
concern in this context, particularly among HIV-infected individuals who do not yet have 
children.  It is important that HIV-infected individuals who are considering childbearing 
have the opportunities to discuss the risks and options, particularly the benefit and 
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